Holen Sie sich die Stockscreener-App
3.08
0.98%
0.03
Handel nachbörslich:
3.13
0.05
+1.62%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LFMD?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$3.05
Offen:
$3.03
24-Stunden-Volumen:
604.65K
Relative Volume:
0.63
Marktkapitalisierung:
$148.46M
Einnahmen:
$219.42M
Nettoeinkommen (Verlust:
$-15.09M
KGV:
-7.4056
EPS:
-0.4159
Netto-Cashflow:
$-3.05M
1W Leistung:
-1.91%
1M Leistung:
-21.03%
6M Leistung:
-1.28%
1J Leistung:
-50.96%
1-Tages-Spanne:
$3.02
$3.10
1-Wochen-Bereich:
$3.02
$3.28
52-Wochen-Spanne:
$2.56
$7.32
Lifemd Inc Stock (LFMD) Company Profile
Firmenname
Lifemd Inc
Sektor
Branche
Telefon
(866) 351-5907
Adresse
236 FIFTH AVENUE, NEW YORK
Compare LFMD vs VEEV, BTSG, TEM, TXG, HQY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LFMD
Lifemd Inc
|
3.08 | 158.10M | 219.42M | -15.09M | -3.05M | -0.4159 |
VEEV
Veeva Systems Inc
|
275.09 | 40.70B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
60.73 | 11.78B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
64.62 | 12.03B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
62.65 | 8.32B | 638.78M | -22.66M | 122.18M | -0.1744 |
HQY
Healthequity Inc
|
96.07 | 8.72B | 1.34B | 230.70M | 440.96M | 2.6695 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-16 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-06-18 | Bestätigt | BTIG Research | Buy |
| 2024-12-10 | Eingeleitet | Lake Street | Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-08-23 | Fortgesetzt | B. Riley Securities | Buy |
| 2024-06-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-11-30 | Eingeleitet | Craig Hallum | Buy |
| 2023-07-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-07-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-03-10 | Eingeleitet | Colliers Securities | Buy |
| 2021-10-04 | Fortgesetzt | B. Riley Securities | Buy |
Alle ansehen
Lifemd Inc Aktie (LFMD) Neueste Nachrichten
LifeMD (LFMD) Session: Ends Lower by 1.76% at $3.34 in Latest Trading; Chart Watch: Price Remains Between $3.17 Support and $3.51 Resistance in the Latest SessionCash Secured Put - vinanet.vn
LifeMD: What The Bulls Got Wrong (NASDAQ:LFMD) - Seeking Alpha
LifeMD (LFMD) Results Review: The Bottom-Line Figure Trails Its Comparison under the Current Snapshot; Trading Move: The Stock Records a 3.98% IncreaseTech Earnings Analysis - vinanet.vn
Q1 2026 LifeMD Inc Earnings Call Transcript - GuruFocus
LifeMD (LFMDP) Results at a Glance: EPS Falls Short of Its Estimate in Latest Trading; Post-Earnings Trading: The Market Price Moves 0.65% Higher in the Latest SessionForward EPS Estimate - vinanet.vn
LifeMD (NASDAQ: LFMD) insider reports stock trade - Stock Titan
LFMDP Preferred Stock Slips 1.1% to $23.25 as Range-Bound Trading PersistsBreadth Thrust - vinanet.vn
Lttl Launches Groundbreaking Telehealth Site for Weight Loss, Longevity, and Wellness - AOL.com
(LFMDP) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Russell Investments Group Ltd. Buys 309,436 Shares of LifeMD, Inc. $LFMD - MarketBeat
Walleye Capital LLC Purchases New Stake in LifeMD, Inc. $LFMD - MarketBeat
HC Wainwright Analysts Boost Earnings Estimates for LifeMD - MarketBeat
LifeMD, Inc. (NASDAQ:LFMD) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
The Rise of Telehealth 'Pill Mills' - AOL.com
LifeMD (LFMD) Q2 2026 Earnings Call Transcript - The Globe and Mail
LifeMD (LFMD) Declines 2.66% to $3.29 as Support at $3.13 Comes into ViewOBV Divergence - vinanet.vn
LifeMD, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:LFMD) 2026-08-11 - Seeking Alpha
H.C. Wainwright Maintains LifeMD(LFMD.US) With Buy Rating, Cuts Target Price to $9 - Moomoo
Renaissance Technologies LLC Trims Stock Holdings in LifeMD, Inc. $LFMD - MarketBeat
LifeMD Inc (LFMD) Stock News Today - TradingKey
LifeMD, Inc. (LFMD) stock price, news, quote and history - Yahoo Finance Singapore
LFMD Maintains Buy Rating by HC Wainwright & Co. -- Price Target Lowered to $9.00 - GuruFocus
LifeMD (NASDAQ:LFMD) Price Target Lowered to $9.00 at HC Wainwright - MarketBeat
Cantor Fitzgerald Remains a Buy on LifeMD (LFMD) - The Globe and Mail
LFMD Maintained by B. Riley Securities -- Price Target Lowered t - GuruFocus
LifeMD, Inc. Stock 12‑Month Price Target Cut to $9, Implies 145% Upside - TradingView
LifeMD (NASDAQ:LFMD) Price Target Cut to $8.00 by Analysts at B. Riley Financial - MarketBeat
B. Riley Adjusts Price Target on LifeMD to $8 From $10, Maintains Buy Rating - Moomoo
LifeMD, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
LFMD Maintained by BTIG -- Price Target Lowered to $9.00 - GuruFocus
BTIG Research Lowers LifeMD (NASDAQ:LFMD) Price Target to $9.00 - MarketBeat
(LFMDP) Risk Channels and Responsive Allocation - Stock Traders Daily
LFMD Looks 36.9% Undervalued on GF Value™ Despite Revenue Foreca - GuruFocus
LFMD Looks 36.9% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
LifeMD August 2026 slides: growth vision meets Q2 execution gap By Investing.com - Investing.com India
LifeMD (NASDAQ:LFMD) Issues Quarterly Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat
LifeMD Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: LifeMD posts Q2 revenue miss, shares sink in after-hours - Investing.com Canada
LifeMD earnings missed by $0.06, revenue fell short of estimates - Investing.com
LifeMD Q2 Earnings Call Highlights - marketbeat.com
LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
UPDATELifeMD Reports Second Quarter 2026 Results - The Manila Times
LifeMD Reports Second Quarter 2026 Results, Reaches Branded GLP-1 Transition Milestone and Raises Full-Year Guidance - quiverquant.com
Is LifeMD Inc (LFMD) Undervalued After Q2 Earnings Miss? EPS of - GuruFocus
LifeMD August 2026 slides: growth vision meets Q2 execution gap - Investing.com
LifeMD Q2 2026 slides tout AI platform, results miss targets - Investing.com
LifeMD, Inc. Q2 2026: Revenue $47.28M, EPS $(0.16) — 10-Q Summary - TradingView
LifeMD Q2 revenue misses estimates as shift to branded GLP-1 therapies weighs - TradingView
LifeMD (NASDAQ: LFMD) posts $15.96M loss but holds $25.1M cash and $30M credit line - Stock Titan
BRIEF-LifeMD Inc Q2 Revenue USD 47.3 Million Vs. IBES Estimate USD 49.2 Million - TradingView
LIFEMD REPORTS SECOND QUARTER 2026 RESULTS - Moomoo
Finanzdaten der Lifemd Inc-Aktie (LFMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lifemd Inc-Aktie (LFMD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| FRIEDEMAN JESSICA | Chief Marketing Officer |
Dec 09 '25 |
Sale |
3.61 |
15,000 |
54,158 |
205,000 |
0.03%
1.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):